![]() | Up a level |
Poh, Mau Ern and Balakrishnan, Sivasubramaniam and Tan, Sin Nee and Abidin, Muhammad Adil Zainal and Liam, Chong Kin and Tan, Jiunn Liang and Pang, Yong Kek and Alaga, Arvindran and Tho, Lye Mun and How, Soon Hin (2024) Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer. Translational Lung Cancer Research, 13 (7). pp. 1649-1659. ISSN 2218-6751, DOI https://doi.org/10.21037/tlcr-24-243.